D.J. St. Germain’s JPMorgan US Quality Factor ETF JQUA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$139M Buy
1,918,286
+2,651
+0.1% +$180K 4.99% 1
2026
Q1
$117M Buy
1,915,635
+15,412
+0.8% +$978K 4.65% 1
2025
Q4
$120M Sell
1,900,223
-32,955
-2% -$2.07M 4.66% 3
2025
Q3
$122M Sell
1,933,178
-428,566
-18% -$26.3M 4.87% 1
2025
Q2
$142M Sell
2,361,744
-448,387
-16% -$25.6M 6.12% 1
2025
Q1
$159M Buy
2,810,131
+127,276
+5% +$7.43M 7.46% 1
2024
Q4
$154M Buy
2,682,855
+44,726
+2% +$2.59M 6.98% 1
2024
Q3
$149M Buy
2,638,129
+67,948
+3% +$3.69M 6.86% 1
2024
Q2
$136M Buy
2,570,181
+158,115
+7% +$8.18M 6.59% 1
2024
Q1
$128M Buy
2,412,066
+108,549
+5% +$5.48M 6.23% 1
2023
Q4
$110M Buy
2,303,517
+125,804
+6% +$5.65M 5.74% 1
2023
Q3
$94.2M Buy
+2,177,713
New +$97.2M 5.3% 3

Other funds holding JQUA

D.J. St. Germain's JQUA Position: Q2 2026 in Review

D.J. St. Germain increased its JPMorgan US Quality Factor ETF (JQUA) stake by 0.14% in Q2 2026, buying an estimated $180K and bringing the position to 1,918,286 shares worth $139M. The position accounts for 4.99% of the portfolio, ranked #1.

D.J. St. Germain first reported a position in JQUA in Q3 2023 and has held it in 12 quarters since. The position peaked at $159M in Q1 2025. 476 funds tracked by Wall St. Rank hold JQUA as of Q2 2026.

  • D.J. St. Germain held 1,918,286 shares of JPMorgan US Quality Factor ETF worth $139M as of Q2 2026.
  • D.J. St. Germain bought 2,651 JPMorgan US Quality Factor ETF shares in Q2 2026, an estimated $180K.
  • JPMorgan US Quality Factor ETF made up 4.99% of D.J. St. Germain's portfolio in Q2 2026, its #1 holding.
  • D.J. St. Germain first reported a position in JPMorgan US Quality Factor ETF in Q3 2023 and has held it in 12 quarters since.
  • D.J. St. Germain's JPMorgan US Quality Factor ETF position peaked at $159M in Q1 2025.
  • 476 funds tracked by Wall St. Rank held JPMorgan US Quality Factor ETF as of Q2 2026.

Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.